Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
emyria
November 27, 2022
Emyria accepted into National Institutes of Health Preclinical Screening Platform for Pain program
August 17, 2022
Ethics Approval for EMD-RX5 – Clinical Trials Next
May 25, 2022
EMD-RX5 demonstrates excellent results in Phase 1 study
June 9, 2021
Investor Webinar | Emyria validated care model
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised